Minerva Neurosciences Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio10.8051.45
P/S Ratio2.42
P/B Ratio-0.60-1.51-0.424.291.90
Price/Tangible Book2.64
Enterprise Value Ratios
EV/Revenue1.64
EV/EBITDA36.24
EV/EBIT36.55
Profitability & Returns
Return on Equity (ROE)-1.65%0.05%
Return on Assets (ROA)-0.29%-0.26%-0.24%-0.28%0.02%
Return on Capital Employed (ROCE)-0.64%-0.43%-0.47%-0.41%0.03%
Leverage & Solvency Ratios
Debt/Equity-2.33-2.88-3.688.320.00
Debt/EBITDA0.05
Liquidity Ratios
Current Ratio7.8512.5729.1522.078.68
Quick Ratio7.5312.2528.4621.558.02
Efficiency Ratios
Asset Turnover0.61
Yield & Distribution Ratios
Earnings Yield0.09%-0.70%-3.78%-1.46%0.02%
FCF Yield-1.26%-0.34%-2.90%-0.72%-0.34%
Buyback Yield-0.16%-0.22%0.00%-0.04%-0.05%